The share prices of major European pharmaceutical companies have jumped in a generally weak market in anticipation of increased orders for vaccine-related products and it is estimated that the average earnings uplift from such an event could amount to around 0.5 percent in both 2009 and 2010," said Jeremy Batstone-Carr, director of private client research at stockbrokers Charles Stanley in London.
The gains weren't just confined to Europe though. In the U.S., a whole host of drug companies like Merck & Co., Pfizer Inc. and Eli Lilly & Co. were in demand too.
Travel stocks suffered though amid worries that passengers could hold back from flying for fear of catching the virus and authorities around the world were preparing to issue advice to passengers.
No comments:
Post a Comment